1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Business Transition Grant for New Entrepreneurs (PAR-27-039 / PAR-27-040) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This program funds small businesses led by first-time Principal Investigators (PIs) in a research project. It provides support for both research and development (R&D) and the PI's mentorship and entrepreneurial training.
It aims to diversify the entrepreneurial workforce in biomedical innovation.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: U.S. small businesses with 500 or fewer employees that meet SBA ownership rules for SBIR or STTR. The proposed PI must have never been an independent PI on an NIH or CDC research grant, or a comparable peer-reviewed research grant elsewhere, and be a U.S. citizen or lawful permanent resident. Confirm the full requirements in the official notice before applying.
The current listing shows not yet published for FY2027. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Small Business Transition Grant for New Entrepreneurs (PAR-27-039 / PAR-27-040) are due January 5, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Small Business Transition Grant for New Entrepreneurs (PAR-27-039 / PAR-27-040) is funded by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This omnibus solicitation supports investigator-initiated Small Business Innovation Research (SBIR) grant applications for projects that do not involve clinical trials. It encourages small businesses to propose innovative solutions across a broad range of topics relevant to the missions of NIH and CDC.
PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This omnibus solicitation supports investigator-initiated Small Business Innovation Research (SBIR) grant applications for projects that involve clinical trials. It aims to fund innovative research and development efforts by small businesses that align with the missions of NIH and CDC.
NOT-OD-26-120 moved the DMS Plan elimination for NIH Career Development awards from October 12, 2027 to effective immediately. Active, pending, and future K applicants are all covered. Here is what changed, what did not, and where the paperwork will lag the policy.
Read articleNIH is carrying its emergency peer review modifications into the January 2027 Advisory Council with more than 35,000 applications in the queue. Discussion drops to 30-35 percent, the middle third becomes "competitive but not discussed" and stays eligible for funding, and the resume of discussion disappears from your summary statement. Here is what each change does to a real application.
Read articleNOT-OD-26-100 took effect October 1, 2026: no more prior approval to modify an approved DMS Plan, no more eRA Commons request type, and one annual RPPR field now carrying the entire record. Here is what that trade actually costs.
Read article